Page last updated: 2024-09-04

imiloxan and cgp 60474

imiloxan has been researched along with cgp 60474 in 1 studies

Compound Research Comparison

Studies
(imiloxan)
Trials
(imiloxan)
Recent Studies (post-2010)
(imiloxan)
Studies
(cgp 60474)
Trials
(cgp 60474)
Recent Studies (post-2010) (cgp 60474)
4502119010

Protein Interaction Comparison

ProteinTaxonomyimiloxan (IC50)cgp 60474 (IC50)
XBP1Homo sapiens (human)0.16
DNA damage-inducible transcript 3 proteinMus musculus (house mouse)0.16
Cyclin-T1Homo sapiens (human)0.013
Cyclin-dependent kinase 1Homo sapiens (human)0.0161
Cyclin-dependent kinase 4Homo sapiens (human)0.216
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.026
Cyclin-A2Homo sapiens (human)0.004
G1/S-specific cyclin-D1Homo sapiens (human)0.216
G1/S-specific cyclin-E1Homo sapiens (human)0.003
Cyclin-dependent kinase 2Homo sapiens (human)0.0041
Serine/threonine-protein kinase mTORHomo sapiens (human)0.8
Cyclin-dependent kinase 7Homo sapiens (human)0.2
Cyclin-dependent kinase 9Homo sapiens (human)0.013
Cyclin-HHomo sapiens (human)0.2
CDK-activating kinase assembly factor MAT1Homo sapiens (human)0.2
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.01
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.01
Serine/threonine-protein kinase SMG1Homo sapiens (human)0.11

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y1

Other Studies

1 other study(ies) available for imiloxan and cgp 60474

ArticleYear
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Science (New York, N.Y.), 2011, Dec-09, Volume: 334, Issue:6061

    Topics: Animals; Antimalarials; Cell Line, Tumor; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Humans; Imidazoles; Liver; Malaria; Mice; Mice, Inbred BALB C; Molecular Structure; Piperazines; Plasmodium; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Polymorphism, Single Nucleotide; Protozoan Proteins; Random Allocation; Small Molecule Libraries; Sporozoites

2011